References |
"Apolipoprotein A-V. A novel apolipoprotein associated with an earlyphase of liver regeneration.";,van Der Vliet H.N., Sammels M.G., Leegwater A.C.J., Levels J.H.M.,Reitsma P.H., Boers W., Chamuleau R.A.F.M.;,J. Biol. Chem. 276:44512-44520(2001)., PubMeb:11577099 DOI:10.1074/jbc.M106888200
"The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.";,Fullerton S.M., Buchanan A.V., Sonpar V.A., Taylor S.L., Smith J.D.,Carlson C.S., Salomaa V., Stengaard J.H., Boerwinkle E., Clark A.G.,Nickerson D.A., Weiss K.M.;,Hum. Genet. 115:36-56(2004).,PubMeb:15108119 DOI:10.1007/s00439-004-1106-x
"The secreted protein discovery initiative (SPDI), a large-scaleeffort to identify novel human secreted and transmembrane proteins: abioinformatics assessment.";,Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,Wood W.I., Godowski P.J., Gray A.M.;,Genome Res. 13:2265-2270(2003)., PubMeb:12975309 DOI:10.1101/gr.1293003
Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
"The status, quality, and expansion of the NIH full-length cDNAproject: the Mammalian Gene Collection (MGC).";,Genome Res. 14:2121-2127(2004).,PubMeb:15489334 DOI:10.1101/gr.2596504
"An apolipoprotein influencing triglycerides in humans and micerevealed by comparative sequencing.";,Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R.,Fruchart J.-C., Krauss R.M., Rubin E.M.;,Science 294:169-173(2001).,PubMeb:11588264 DOI:10.1126/science.1064852
"Structure-function studies of human apolipoprotein A-V: a regulatorof plasma lipid homeostasis.";,Beckstead J.A., Oda M.N., Martin D.D.O., Forte T.M., Bielicki J.K.,Berger T., Luty R., Kay C.M., Ryan R.O.;,Biochemistry 42:9416-9423(2003).,PubMeb:12899628 DOI:10.1021/bi034509t
"The human apolipoprotein AV gene is regulated by peroxisomeproliferator-activated receptor-alpha and contains a novel farnesoidX-activated receptor response element.";,Prieur X., Coste H., Rodriguez J.C.;,J. Biol. Chem. 278:25468-25480(2003).,PubMeb:12709436 DOI:10.1074/jbc.M301302200
"Structure and interfacial properties of human apolipoprotein A-V.";,Weinberg R.B., Cook V.R., Beckstead J.A., Martin D.D.O.,Gallagher J.W., Shelness G.S., Ryan R.O.;,J. Biol. Chem. 278:34438-34444(2003).,PubMeb:12810715 DOI:10.1074/jbc.M303784200
"The novel apolipoprotein A5 is present in human serum, is associatedwith VLDL, HDL, and chylomicrons, and circulates at very lowconcentrations compared with other apolipoproteins.";,O'Brien P.J., Alborn W.E., Sloan J.H., Ulmer M., Boodhoo A.,Knierman M.D., Schultze A.E., Konrad R.J.;,Clin. Chem. 51:351-359(2005).,PubMeb:15528295 DOI:10.1373/clinchem.2004.040824
"Normal binding of lipoprotein lipase, chylomicrons, and apo-AV toGPIHBP1 containing a G56R amino acid substitution.";,Gin P., Beigneux A.P., Davies B., Young M.F., Ryan R.O., Bensadoun A.,Fong L.G., Young S.G.;,Biochim. Biophys. Acta 1771:1464-1468(2007).,PubMeb:17997385 DOI:10.1016/j.bbalip.2007.10.005
"An initial characterization of the serum phosphoproteome.";,Zhou W., Ross M.M., Tessitore A., Ornstein D., Vanmeter A.,Liotta L.A., Petricoin E.F. III;,J. Proteome Res. 8:5523-5531(2009).,PubMeb:19824718 DOI:10.1021/pr900603n
"Two independent apolipoprotein A5 haplotypes influence human plasmatriglyceride levels.";,Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M.,Cohen J.C.;,Hum. Mol. Genet. 11:3031-3038(2002).,PubMeb:12417524 DOI:10.1093/hmg/11.24.3031
"Ser19Trp polymorphism within the apolipoprotein AV gene inhypertriglyceridaemic people.";,Vrablik M., Horinek A., Ceska R., Adamkova V., Poledne R.,Hubacek J.A.;,J. Med. Genet. 40:E105-E105(2003).,PubMeb:12920097 DOI:10.1136/jmg.40.8.e105
"A novel genetic variant in the apolipoprotein A5 gene is associatedwith hypertriglyceridemia.";,Kao J.-T., Wen H.-C., Chien K.-L., Hsu H.-C., Lin S.-W.;,Hum. Mol. Genet. 12:2533-2539(2003).,PubMeb:12915450 DOI:10.1093/hmg/ddg255
"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemiadue to lipoprotein lipase impairment.";,Marcais C., Verges B., Charriere S., Pruneta V., Merlin M., Billon S.,Perrot L., Drai J., Sassolas A., Pennacchio L.A., Fruchart-Najib J.,Fruchart J.C., Durlach V., Moulin P.;,J. Clin. Invest. 115:2862-2869(2005).,PubMeb:16200213 DOI:10.1172/JCI24471 |
